Trials / Sponsors / The United Bio-Technology (Hengqin) Co., Ltd.
The United Bio-Technology (Hengqin) Co., Ltd.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) Metabolic Dysfunction-associated Steatohepatitis (MASH) | Phase 2 | 2025-09-30 |
| Recruiting | UBT251 Injection Phase II Clinical Study (CKD) Obesity &Amp; Overweight, Chronic Kidney Disease | Phase 2 | 2025-09-01 |
| Active Not Recruiting | UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Study Type 2 Diabetes Mellitus (T2DM) | Phase 2 | 2025-03-22 |
| Active Not Recruiting | UBT251 Injection Phase II Study (Overweight or Obesity) Obesity &Amp; Overweight | Phase 2 | 2025-03-10 |